pSTAT3 in luminal breast cancer - results from BIG-2-98 trial
12 May 2017
pSTAT3 in luminal breast cancer - results from BIG-2-98 trial
Adaptive trial design on breast cancer
The molecular characterisation of oesophageal adenocarcinoma
Discovering genes in mammary cancer by insertional mutagenesis
Hallmarks of cancer cell development
Pembrolizumab and indoximod for melanoma
Nivolumab for NSCLC: five years on
Long-term clinical outcomes and analyses of atezolizumab for mTNBC
Final overall survival analysis of MONARCH 1
Redefining tamoxifen for breast cancer
Treatment choices for HER2 amplified colorectal cancer
Final results of the HERACLES trial in HER2-amplified colorectal cancer